This throat swab test screens for colonisation with multidrug-resistant Gram-negative bacteria, including carbapenemase-producing organisms. It suits people being admitted to or discharged from healthcare settings.
1 biomarker as listed by Better2Know.
Multidrug-resistant Gram-negative (MRGN) bacteria, including carbapenemase-producing organisms, resist many commonly used antibiotics. This test uses a throat swab to check for colonisation, which can happen without symptoms but is relevant before hospital admission or discharge, or in settings with a known outbreak. A positive result flags colonisation for infection control purposes rather than diagnosing an active infection.
There is no comparison group listed for this test, so we cannot benchmark it against a direct peer. Against the wider set of immunity and infection tests we track, £239 sits well above the £129 median for that category.
The scores reflect a clearly presented listing and strong collection convenience, since a home nurse visit is offered alongside the clinic option. It loses marks on price, which runs well above the category median, and on results and follow-up, because it is not doctor-reviewed as standard.
This suits people being admitted to or discharged from a hospital or care facility, those with recent antibiotic use or recurrent infections, or anyone monitoring infection control after exposure to a known MRGN outbreak. There is no comparison group listed for this test, so if price is the deciding factor, it is worth checking whether a lower-cost throat swab from another provider covers the same organisms.
A throat swab is taken either at a clinic or during a home nurse visit. It is sent to the laboratory and cultured to check for multidrug-resistant Gram-negative bacteria, including carbapenemase-producing organisms. Results are typically available within five days through your online patient area. The sheet does not state that results are doctor-reviewed as standard.
This throat swab checks for colonisation with multidrug-resistant Gram-negative bacteria, with a home nurse visit option and results in five days. At £239 it sits well above the £129 median for the immunity tests we track, and results are not doctor-reviewed as standard.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
1 biomarkers, placing it in the 36th percentile of immunity tests we track.
A swab sample taken at a clinic; a home nurse visit is offered; results in around 5 days, slower than similar tests.
Results are not doctor-reviewed and no consultation is included; the provider does not describe the report format.
Trustpilot 4.2 from 775 reviews; CQC registered; trading 18+ years.
£239.00 against a median of £129.00 for the 79 similarly sized immunity tests we track (+85%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
